Browsing by Author "Kaplan, Richard"

Now showing 1 - 2 of 2

Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy : Results of the Randomized FOCUS4-N Trial
(2021-11-20) Adams, Richard A.; Fisher, David J.; Graham, Janet; Seligmann, Jenny F.; Seymour, Matthew; Kaplan, Richard; Yates, Emma; Parmar, Mahesh; Richman, Susan D.; Quirke, Philip; Butler, Rachel; Brown, Ewan; Collinson, Fiona; Falk, Stephen; Wasan, Harpreet; Shiu, Kai-Keen; Middleton, Gary; Samuel, Leslie; Wilson, Richard H.; Brown, Louise C.; Maughan, Timothy S.; FOCUS Trial Collaboration; University of Aberdeen.Medicine, Medical Sciences & Nutrition; University of Aberdeen.Aberdeen Centre for Evaluation
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D) : a phase 2–3 randomised trial
(2018-03) Adams, Richard; Brown, Ewan; Brown, Louise; Butler, Rachel; Falk, Stephen; Fisher, David; Kaplan, Richard; Quirke, Phil; Richman, Susan; Samuel, Leslie; Seligman, Jenny; Seymour, Matt; Shui, Kai Keen; Wasan, Harpreet; Wilson, Richard; Maughan, Tim; University of Aberdeen.Aberdeen Centre for Evaluation